San Diego, California–(Newsfile Corp. – April 20, 2021) – Tryp Therapeutics Inc. ( CSE: TRYP) (OTCQB: TRYPF) (“Tryp” or the “Company“), a pharmaceutical company focused on developing clinical-stage compounds for diseases with unmet medical needs, reported today on the Company’s significant progress since successfully completing its Initial Public Offering in December 2020. Tryp is advancing two…


Previous articleThe “Equity Elephant”: Why Psychedelic Mutualism and Cooperatives are Crucial for an Accessible Future
Next articlePT240 – Ralph Blumenthal – Alien Abductions and The Believer